Found: 28
Select item for more details and to access through your institution.
Development and psychometric assessment of self-reported patient medication safety scale (SR-PMSS).
- Published in:
- Therapeutic Advances in Drug Safety, 2023, v. 14, p. 1, doi. 10.1177/20420986231152934
- By:
- Publication type:
- Article
Assessing adverse drug reaction reports for antidiabetic medications approved by the food and drug administration between 2012 and 2017: a pharmacovigilance study.
- Published in:
- Therapeutic Advances in Drug Safety, 2023, v. 14, p. 1, doi. 10.1177/20420986231181334
- By:
- Publication type:
- Article
Modified Dixon sequential method to determine the effective dose of alfentanil compounded with propofol for day-case hysteroscopy.
- Published in:
- Therapeutic Advances in Drug Safety, 2023, v. 14, p. 1, doi. 10.1177/20420986231214992
- By:
- Publication type:
- Article
Physiologically based pharmacokinetic modeling of candesartan to predict the exposure in hepatic and renal impairment and elderly populations.
- Published in:
- Therapeutic Advances in Drug Safety, 2023, v. 14, p. 1, doi. 10.1177/20420986231220222
- By:
- Publication type:
- Article
Evaluation of four machine learning models for signal detection.
- Published in:
- Therapeutic Advances in Drug Safety, 2023, v. 14, p. 1, doi. 10.1177/20420986231219472
- By:
- Publication type:
- Article
Acceptability of a cross-sectoral hospital pharmacist intervention for patients in transition between hospital and general practice: a mixed methods study.
- Published in:
- Therapeutic Advances in Drug Safety, 2023, v. 14, p. 1, doi. 10.1177/20420986231213714
- By:
- Publication type:
- Article
Opportunities and challenges of pharmacovigilance in special populations: a narrative review of the literature.
- Published in:
- Therapeutic Advances in Drug Safety, 2023, v. 14, p. 1, doi. 10.1177/20420986231200746
- By:
- Publication type:
- Article
Understanding, readiness, and response of healthcare professionals in combating falsified medical products in Eritrea: a population-based survey.
- Published in:
- Therapeutic Advances in Drug Safety, 2023, v. 14, p. 1, doi. 10.1177/20420986231213713
- By:
- Publication type:
- Article
HIV/AIDS patients' knowledge, attitude, and practice toward anti-retroviral therapy medications' adverse effects and associated factors in Tikur Anbessa Specialized Hospital.
- Published in:
- Therapeutic Advances in Drug Safety, 2023, v. 14, p. 1, doi. 10.1177/20420986231194752
- By:
- Publication type:
- Article
Inappropriate quetiapine use at a large academic medical center: frequency of misuse and associated costs of adverse effects.
- Published in:
- Therapeutic Advances in Drug Safety, 2023, v. 14, p. 1, doi. 10.1177/20420986231213173
- By:
- Publication type:
- Article
Enhancing self-medication practices in the era of infodemic: the role of pharmacovigilance.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
Hospital admissions attributed to adverse drug reactions in tertiary care in Uganda: burden and contributing factors.
- Published in:
- Therapeutic Advances in Drug Safety, 2023, v. 14, p. 1, doi. 10.1177/20420986231188842
- By:
- Publication type:
- Article
Survival outcomes of beta-blocker usage in HER2-positive advanced breast cancer patients: a retrospective cohort study.
- Published in:
- Therapeutic Advances in Drug Safety, 2023, v. 14, p. 1, doi. 10.1177/20420986231181338
- By:
- Publication type:
- Article
Clinical relevance of potential self-medication drug interactions in antineoplastic and immune-modulating therapy among online pharmacy customers.
- Published in:
- Therapeutic Advances in Drug Safety, 2023, v. 14, p. 1, doi. 10.1177/20420986231188845
- By:
- Publication type:
- Article
Joint use of population pharmacokinetics and machine learning for optimizing antiepileptic treatment in pediatric population.
- Published in:
- Therapeutic Advances in Drug Safety, 2023, v. 14, p. 1, doi. 10.1177/20420986231181337
- By:
- Publication type:
- Article
Funding and financial sustainability of pharmacovigilance: suggested models for funding pharmacovigilance in resource-limited African countries.
- Published in:
- Therapeutic Advances in Drug Safety, 2023, v. 14, p. 1, doi. 10.1177/20420986231188836
- By:
- Publication type:
- Article
Flow rate accuracy of infusion devices within healthcare settings: a systematic review.
- Published in:
- Therapeutic Advances in Drug Safety, 2023, v. 14, p. 1, doi. 10.1177/20420986231188602
- By:
- Publication type:
- Article
Safety monitoring of oral iron supplements in pregnant women with anemia: a multi-center observational clinical study.
- Published in:
- Therapeutic Advances in Drug Safety, 2023, v. 14, p. 1, doi. 10.1177/20420986231181335
- By:
- Publication type:
- Article
Risk of lower limb amputation in diabetic patients using SGLT2 inhibitors versus DPP4 inhibitors or GLP-1 agonists: a meta-analysis of 2 million patients.
- Published in:
- Therapeutic Advances in Drug Safety, 2023, v. 14, p. 1, doi. 10.1177/20420986231178126
- By:
- Publication type:
- Article
Patient-centered pharmacovigilance: priority actions from the inherited bleeding disorders community.
- Published in:
- Therapeutic Advances in Drug Safety, 2023, v. 14, p. 1, doi. 10.1177/20420986221146418
- By:
- Publication type:
- Article
The 6th European Pharmacovigilance Congress: speaker abstracts.
- Published in:
- Therapeutic Advances in Drug Safety, 2023, v. 14, p. 1, doi. 10.1177/20420986221144584
- Publication type:
- Article
Association between proton pump inhibitors and rhabdomyolysis risk: a post-marketing surveillance using FDA adverse event reporting system (FAERS) database.
- Published in:
- Therapeutic Advances in Drug Safety, 2023, v. 14, p. 1, doi. 10.1177/20420986231154075
- By:
- Publication type:
- Article
Therapy of women with multiple sclerosis: an analysis of the use of drugs that may have adverse effects on the unborn child in the event of (unplanned) pregnancy.
- Published in:
- Therapeutic Advances in Drug Safety, 2023, v. 14, p. 1, doi. 10.1177/20420986221143830
- By:
- Publication type:
- Article
Serious neurological adverse events following immunization against SARS-CoV-2: a narrative review of the literature.
- Published in:
- Therapeutic Advances in Drug Safety, 2023, v. 14, p. 1, doi. 10.1177/20420986231165674
- By:
- Publication type:
- Article
Impact of risk communication on patient's safety during the pandemic.
- Published in:
- Therapeutic Advances in Drug Safety, 2023, v. 14, p. 1, doi. 10.1177/20420986231159752
- By:
- Publication type:
- Article
Developing and piloting a cross-sectoral hospital pharmacist intervention for patients in transition between hospital and general practice.
- Published in:
- Therapeutic Advances in Drug Safety, 2023, v. 14, p. 1, doi. 10.1177/20420986231159221
- By:
- Publication type:
- Article
Analysis of the nature and contributory factors of medication safety incidents following hospital discharge using National Reporting and Learning System (NRLS) data from England and Wales: a multi-method study.
- Published in:
- Therapeutic Advances in Drug Safety, 2023, v. 14, p. 1, doi. 10.1177/20420986231154365
- By:
- Publication type:
- Article
Development of a checklist for the assessment of pharmacovigilance guidelines in Southern Africa: a document review.
- Published in:
- Therapeutic Advances in Drug Safety, 2023, v. 14, p. 1, doi. 10.1177/20420986221143272
- By:
- Publication type:
- Article